A carregar...

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

The genes encoding MDM2 and CDK4 are frequently co-amplified in sarcomas, and inhibitors to both targets are approved or clinically tested for therapy. However, we show that inhibitors of MDM2 and CDK4 antagonize each other in their cytotoxicity towards sarcoma cells. CDK4 inhibition attenuates the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Sriraman, Anusha, Dickmanns, Antje, Najafova, Zeynab, Johnsen, Steven A., Dobbelstein, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133967/
https://ncbi.nlm.nih.gov/pubmed/30206211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0968-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!